Liver Cancer Clinical Trials

A listing of Liver Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 719 clinical trials
RFA Using Combined Bipolar and Monopolar Energy Deliver With Twin Cooled-Wet Electrodes

In this study, a dual / Twin Cooled-wet electrode was used to perform RFA therapy on residual tumors after transarterial chemo-embolization and to find out the therapeutic results. The primary endpoint is the 12-month local recurrence rate, and the secondary endpoint is the survival rate, disease-free survival rate, actual procedure …

cancer
metastasis
  • 0 views
  • 28 Mar, 2021
RFA Using Gradual RF Energy Delivery Mode With Octopus Electrodes

The investigators intend to perform RFA therapy on HCC less than 4 cm in size using octopus electrode, double alternating unipolar high-frequency transmission mode and gradual high-frequency energy loading mode, and to find out the therapeutic results. The primary evaluation variable is the ideal technical success rate for securing a …

hepatitis
cirrhosis
  • 0 views
  • 28 Mar, 2021
  • 1 location
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596)

This is a multicenter, open-label study conducted in two phases: Phase 1 consisting of a CGX1321 Single Agent Dose Escalation Phase in solid tumors, CGX1321 Single Agent Dose Expansion Phase in GI tumors and Roll-over Cohort of CGX1321 and pembrolizumab in subjects who have progressed on single agent CGX1321 and …

solid tumour
measurable disease
pembrolizumab
  • 11 views
  • 24 Mar, 2022
  • 6 locations
Possible Differences in HCC Course Depending on DAA Treatment

BACKGROUND It is estimated that around 71 milion people live with chronic hepatitis C virus (HCV) infection. This may lead to the development of liver cirrhosis and hepatocellular carcinoma (HCC). Liver cirrhosis is considered as one of the most common risk factors of hepatocellular carcinoma (HCC). HCC is seventh most …

hepatocellular carcinoma
elastography
carcinoma
meld score
hepatitis
  • 0 views
  • 25 May, 2022
  • 1 location
A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid Tumors

The Phase 1b part of this study is conducted to assess the safety and tolerability of E7386 in combination with pembrolizumab in participants with previously treated selected solid tumors, and to determine the recommended Phase 2 dose (RP2D) of E7386 in combination with pembrolizumab. The Phase 2 part of this …

systemic therapy
pembrolizumab
braf inhibitor
carcinoma
BRAF
  • 0 views
  • 11 Aug, 2022
  • 5 locations
Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Solid Tumors (MK-6482-016)

The purpose of this study is to determine the safety and efficacy of belzutifan in combination with pembrolizumab and lenvatinib in multiple solid tumors including hepatocellular carcinoma (HCC), colorectal cancer (CRC), pancreatic ductal adenocarcinoma (PDAC), biliary tract cancer (BTC), endometrial cancer (EC),and esophageal squamous cell carcinoma (ESCC). There is no …

pembrolizumab
vegf
oxaliplatin
carcinoma
gemcitabine
  • 0 views
  • 11 Aug, 2022
  • 40 locations
Inovio TRT-001: Telomerase DNA Immunotherapy in Breast Lung and Pancreatic Cancers

This is a Phase I, open label study to evaluate the safety, tolerability, and immunogenicity of INO-1400 alone or in combination with INO-9012, delivered by electroporation in subjects with high risk breast, lung, or pancreatic cancer with no evidence of disease after surgery and adjuvant therapy. Subjects will be enrolled …

adjuvant therapy
pancreatic cancers
cancer
  • 72 views
  • 07 Nov, 2020
  • 3 locations
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Phase 1, first-in-human, open label study of CAR macrophages in HER2 overexpressing solid tumors.

bone marrow procedure
HER2
erbb2
primary cancer
cancer
  • 0 views
  • 24 Mar, 2022
  • 5 locations
18F-FAPI PET in the Diagnosis of Liver Fibrosis

It is an open label observation clinical trial, all participants are chronic liver disease. The investigators deem to make a novel evaluate criteria to hepatic fibrosis. The point of the clinical trial is to evaluate the novel biomaker 18F-FAPI-04 by PET-CT scan in the evaluation of the hepatic fibrosis.

liver disease
hepatic fibrosis
hepatitis
biopsy of liver
fibrosis
  • 0 views
  • 12 Mar, 2022
  • 1 location
Clinical Characteristics, Natural Outcome and Treatment Optimization of Refractory

Refractory hepatitis B is to point to although standard application nucleoside (acid) analogue treatment undertakes primary treatment and two strengthen treatment, but existence is persistent viremia. Currently, there is no consensus on salvage therapy for patients who remain virus-positive after a second round of antiviral therapy. This is the first …

antiviral drugs
  • 0 views
  • 29 May, 2022
  • 13 locations